OBN’s Corporate Membership of 400-plus organisations includes many R&D companies (therapeutic, medical technology and diagnostics) as well as an extensive range of contract research (CRO) and manufacturing (CMO) organisations, companies in the associated industries and specialists suppliers.
The membership breakdown by sector can be accessed by clicking on the down arrow on the right of the search box.
Search for companies by:
- Sector/Subsector using the dropdown box below
- Keyword search using the box on the right
- Alphabetical listing
Please note that only details of current OBN Members appear here.
EUSA PharmaEUSA PharmaEUSA Pharma is a newly formed specialty pharmaceutical company headquartered in the UK which supplies medicines and medical devices across Europe through its own operations, and worldwide through a network of partners in over 40 countries.
EUSA Pharma is a newly formed specialty pharmaceutical company headquartered in the UK which supplies medicines and medical devices across Europe through its own operations, and worldwide through a network of partners in over 40 countries.
Exonate LtdExonate LtdExonate is focused on the discovery and development of small molecule drugs that inhibit mRNA splicing. The initial targets are within angiogenic pathways for use in treatment of eye disease and oncology
Exonate Limited is a speciality pharmaceutical company recently spun out of The University of Nottingham. It focuses on the discovery and development of the first in a new class of drugs–SPHINXes–that inhibit mRNA splicing. mRNA splicing is a fundamental biological process crucial for normal physiology that is altered in disease states resulting in pathological blood vessel formation (angiogenesis), which is a key driver of disease progression in ophthalmic conditions and cancer.
Contacts: Beverly Bramley, firstname.lastname@example.org